Highest-materiality recent filing
Amesite secures largest NurseMagic™ deployment with ~2,700-patient census
New enterprise customer deploying NurseMagic™ across its workforce; represents largest deployment to date.
Amesite raises $2.6M upfront in offerings; up to $6M including warrants
Gross proceeds: ~$2M from institutional registered direct & private placement.
Amesite posts Q4 2026 shareholder update presentation; no specific data in filing
Presentation materials titled 'Q4 2026 Shareholder Update empowering people with ai tools' posted to company website on April 20, 2026.
Amesite reports 69% QoQ revenue growth in Q2 2026, plans AI-powered EMR launch
Q2 2026 revenue rose 69% QoQ; operating expenses cut.
Notified by Nasdaq on Oct 28, 2025 for non-compliance with Listing Rule 5550(b)(1) requiring $2.5M in stockholders' equity.
Amesite dismisses auditor Turner Stone, appoints Novogradac; 2024 audit included going-concern note
Dismissed Turner, Stone & Company, L.L.P. on June 24, 2025; Audit Committee approved the termination.
Amesite Q3 revenue up 2.4x sequentially; user growth 1,340% in paid subscription launch quarter
Revenue increased 2.4x from Q2 to Q3, driven by NurseMagic app, with even B2B/B2C split.
Amesite releases corporate intro video featuring NurseMagic mobile healthcare app
Video released Feb 18, 2025, on newly redesigned website at amesite.com.
Amesite presents 2025 outlook at Sidoti Conference; no specific financial guidance
Management presented at the Sidoti Micro-Cap Virtual Conference on January 22, 2025.
Amesite Inc. stockholders elect Class I director and ratify auditor at annual meeting
J. Michael Losh elected Class I director with 823,430 votes for, 31,297 withheld, 470,032 broker non-votes.
Amesite closes $3.6M best-efforts offering; regains Nasdaq equity compliance
Sold 1,201,667 shares at $3.00 each, gross proceeds $3.6M, net ~$3.08M.
Amesite directors Barkett and Ogawa resign effective Dec 23, 2024
Anthony Barkett resigned from the Board for personal reasons, effective December 23, 2024.
Amesite releases year-end presentation; no specific details in filing text
Amesite furnished a shareholder update presentation on December 23, 2024, filed as Exhibit 99.1.
Amesite (AMST) receives Nasdaq delisting notice for failure to meet $2.5M stockholders' equity rule
Received Nasdaq deficiency letter on Nov 26, 2024 for non-compliance with Listing Rule 5550(b)(1) requiring $2.5M stockholders' equity.
Sherlyn W. Farrell's engagement not renewed; Sarah Berman appointed effective Dec 15, 2024.
Presentation materials furnished as Exhibit 99.1 and posted to company website on September 17, 2024.
Amesite posts shareholder presentation; no material new financial details provided
Management posted Summer 2024 presentation materials following shareholder update on July 25, 2024.
Beta registration open for PREACTO app; uses AI for threat assessment, safety planning, and notifications.
Amesite shareholders approve 2018 Equity Plan amendment, increasing share reserve by 508,488 shares
Special meeting held June 18, 2024; 942,208 shares voted, quorum present.
Amesite amends bylaws to set quorum at 33 1/3% of outstanding voting shares
Board adopted amendment reducing quorum from majority to 33-1/3% of outstanding voting shares.
Amesite presents corporate update; $3.7M cash, no debt, 6 new higher-ed deals since pivot
Cash and equivalents of $3.7M, zero debt; average monthly burn projected at $297K over next 12 months.
Amesite furnishes Spring 2024 investor presentation; no specific details in filing text
Presentation posted to company website on February 20, 2024; furnished as Exhibit 99.1.
Amesite issues 250k restricted shares to Laidlaw & Company for advisory services
On Jan 31, 2024, Amesite agreed to issue 250,000 shares of restricted common stock to Laidlaw & Company (UK) Ltd.
Amesite stockholders elect three directors and ratify auditor at annual meeting
Elected Anthony M. Barkett (879,831 for, 22,793 withheld), Gilbert S. Omenn (879,774 for, 22,850 withheld), George Parmer (891,371 for, 11,253 withheld); broker non-votes 452,466 each.
Opening keynote on Oct 2, 2023 at 5pm PDT with LD Micro CEO Chris Lahiji discussing 'How AI Is Eating Software'.
Amesite presents at Sidoti conference; highlights GPT-4 integration and course onboarding
Onboarded 53 courses in 4 days and trained 1,000 global employees as of Feb 14, 2023.
Amesite confirms no exposure to Silicon Valley Bank failure
Amesite Inc. states it holds no deposits, securities, or accounts at Silicon Valley Bank.
Amesite regains Nasdaq minimum bid price compliance, removes delisting risk
Nasdaq confirmed Amesite regained compliance with $1.00 minimum bid price on March 7, 2023 after 10 consecutive trading days.
Amesite issues shareholder update presentation on Feb 27, 2023; content not disclosed in filing
Presentation posted on company website's media section on February 27, 2023.
Amesite stockholders approve reverse stock split; equity plan amendment fails
Reverse stock split authorized at ratio between 1:5 and 1:50, board to set exact ratio within one year.
Amesite effects 1-for-12 reverse stock split to meet Nasdaq bid price; equity plan expanded
Reverse stock split at 1-for-12 ratio effective pre-market Feb 22, 2023; post-split shares ~2.53M.
Amesite dismisses Deloitte as auditor, appoints Turner Stone; going concern emphasis in prior audit
On Jan 27, 2023, Amesite dismissed Deloitte & Touche as its independent auditor and appointed Turner, Stone & Company.
Amesite furnishes presentation for Sidoti conference; no material details disclosed
Presentation materials furnished under Item 7.01 for Sidoti January Micro-Cap Virtual Conference.
Amesite Sells 100,000 Shares of Series A Preferred Stock to Board Member George Parmer
Amesite issued 100,000 shares of Series A Preferred Stock to director George Parmer for $1,000 on January 13, 2023.
Amesite stockholders elect Sastry and Brewer as Class I directors, ratify Deloitte as auditor
Ann Marie Sastry re-elected with 12,314,140 for, 487,830 withheld; 3,538,340 broker non-votes.
Amesite appoints Sherlyn Farrell as CFO, replacing Mark Corrao
Sherlyn Farrell, age 60, appointed CFO effective December 15, 2022, succeeding Mark Corrao whose engagement was not renewed.
Amesite submits NIST RFI response for semiconductor institute; touts NAFEO partnership
Submitted response to NIST RFI on potential semiconductor manufacturing USA institutes under CHIPS Act.
Amesite case study with EWIE Group: 91% employee scores, 50 courses onboarded in 4 days
Case study covers upskilling training for nearly 1,000 employees across 10 countries.
Amesite announces five new HBCUs join NAFEO alliance; COE fundraising target $30M
Five universities (Alabama State, Allen, Benedict, Clark Atlanta, Univ of DC) join NAFEO's Center for Opportunity and Equity.
Amesite raises $2.3M in registered direct offering and private placement of warrants
Gross proceeds of $2.3M from sale of 4,181,821 common shares and warrants to purchase 4,181,821 shares at combined price $0.55.
Amesite amends NAFEO MSA effective date; HBCU platform with $30M fundraising target
Corrected NAFEO MSA effective date to August 17, 2022; three-year term with auto-renewal.
3-year MSA with NAFEO to provide LCE platform for HBCUs; auto-renews for successive 3-year terms.
Amesite reports 29% revenue growth in first nine months of FY2022; cash burn down 13.5% YoY in Q3
Revenue growth for first nine months of FY2022 approximately 29% vs prior year.
Presentation titled 'Attention! How to Grab and Maintain Your Learners’ Interest & Engagement' used at ATD 2022.
Amesite files investor presentation; no specific financial details provided
Presentation furnished as Exhibit 99.1 used at Q2 Investor Summit on May 5, 2022.
Amesite furnishes investor presentation and business update; no specific details disclosed in filing
Company prepared presentation materials for use at ASU+GSV Summit on April 4, 2022 (Ex-99.1).
Amesite receives Nasdaq bid price non-compliance notice; launches CUNY professional learning portal
Received Nasdaq deficiency letter on March 8, 2022 for failure to maintain $1.00 minimum bid price over 30 consecutive business days.
Amesite furnishes investor presentation for Aegis Virtual Event; no earnings or guidance disclosed
Management presented at Aegis Virtual Event on February 24, 2022, using the investor presentation.
Amesite closes public offering of 3.75M shares at $0.80, raising $3M gross / $2.58M net
Priced best-efforts offering of 3,437,500 shares at $0.80/share on Feb 11; size increased to 3,750,000 on Feb 14.
Amesite publishes investor presentation for Benzinga All Access Conference
Presentation covers multi-billion dollar online learning market opportunity in business and education.
authorized and approved the appointment of Sarah Berman as Principal Financial and Accounting Officer of the Company effective December 15, 2024.
the Board determined not to renew the engagement of Sherlyn W. Farrell, who previously served as the Company’s Chief Financial Officer since December 15, 2022.
On December 9, 2022, the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the appointment of Sherlyn W. Farrell, age 60, as Chief Financial Officer of the Company effective December 15, 2022.
the Board determined not to renew the engagement of Mark Corrao, who previously served as the Company’s Chief Financial Officer since December 15, 2021 for a term of one year in accordance with the CFO Agreement between the Company and Mr. Corrao.
On December 15, 2021 (the “Effective Date”), the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the termination of Matthew Kern as Chief Financial Officer of the Company, effective as of the Effective Date.
In addition, on December 15, 2021, in connection with the termination of Mr. Kern, the Board authorized and approved the appointment of Mark Corrao, age 64, as Chief Financial Officer of the Company.
Max materiality 0.75 · Median 0.50 · Most common event other_material